Loss of response to antidepressants and subsequent refractoriness: Diagnostic issues in a retrospective case series

Journal of Affective Disorders

Volumn 64, Issue 1, 2001, Pages 99-106

  Sharma, Verinder ^a,b  

^a London Psychiatric Hospital   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Antidepressants; Bipolar disorder; Drug therapy; Loss of response; Major depression

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; AMOXAPINE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CHLORPROMAZINE; CLOMIPRAMINE; CLONAZEPAM; DEXAMPHETAMINE; DIAZEPAM; FLUOXETINE; IMIPRAMINE; LEVOMEPROMAZINE; LIOTHYRONINE; LITHIUM; LITHIUM CARBONATE; MOCLOBEMIDE; NEFAZODONE; OLANZAPINE; PAROXETINE; PHENELZINE; RISPERIDONE; SERTRALINE; TRANQUILIZER; TRIMIPRAMINE; UNINDEXED DRUG; VALPROATE SEMISODIUM; VENLAFAXINE; ZOPICLONE;

ADD ON THERAPY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; LONG TERM CARE; MALE; MANIC DEPRESSIVE PSYCHOSIS; MOOD; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 0035065894     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(00)00212-3     Document Type: Article

References (41)

1. Affective disorders in referred children and younger siblings of manic-depressives: Mode of onset and prospective course
2. Fluoxetine efficacy in treatment resistant depression
3. Clinical course of affective disorders
4. The prevalence and distribution of major depression in a national community sample: The national co-morbidity survey
5. Loss of antidepressant efficacy during maintenance therapy: Possible mechanisms and treatments
6. Psychiatrists' responses to failure of maintenance therapy with antidepressants
7. Poor response to fluoxetine: Underlying depression, serotonergic overstimulation, or a 'therapeutic window'?
8. A proposed new approach to the clinical subclassification of depressive illness
9. Change in serum antidepressant level at a constant dose of medication
10. Tolerance to antidepressants
11. Tolerance to therapeutic effects of antidepressants
12. The unipolar-bipolar distinction in the depressive disorders
13. Tolerance to phenelzine and subsequent refractory depression: Three cases
14. Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: A double-blind, controlled study
15. Relapse in patients on long-term fluoxetine treatment: Response to increased fluoxetine dose
16. CNS stimulant potentiation of monoamine oxidase inhibitors in treatment-refractory depression
17. Mood stabilizer combinations: A review of safety and efficacy
18. A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients
19. Lithium carbonate treatment in depression and mania: A longitudinal double-blind study
20. A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression
21. Long-term treatment of depression
22. Antidepressant tachyphylaxis
23. Bromocriptine treatment of relapses seen during selective serotonin re-uptake inhibitor treatment of depression
24. Lithium in the treatment of depression
25. Combination of fluoxetine with pemoline in the treatment of major depressive disorder
26. Common mental disorders and disability across cultures: Results from the WHO collaborative study on psychological problems in general health care
27. Outcome of depression in psychiatric settings
28. Antidepressant effects of carbamazepine
29. Loss of drug effects during continuation therapy
30. Further evidence that a placebo response to antidepressants can be identified
31. Postpartum psychoses in patients with manic depressive disease
32. Lithium as a prophylatic agent in unipolar affective illness: Comparison with cyclic antidepressants
33. Lithium augmentation of valproic acid in treatment resistant depression
34. Venlafaxine: Loss of antidepressant effect and its management
35. Bipolar illness in adolescents with major depression: Clinical, genetic, and psychopharmacologic predictors in a three- to four-year prospective follow-up investigation
36. Tolerance to antidepressants
37. Is delusional depression related to bipolar disorder?
38. The course of depression in adult outpatients. Results from the medical outcomes study